VS
stockvs
Go to ScreenerHub
0QQ6.L

0QQ6.L vs JNJ

JNJ

In the past 12 months, JNJ returned +49% while 0QQ6.L gained 1%.

ValuationGrowthProfitabilityBalance SheetPerformance
0QQ6.L
0QQ6.L

Roche Holding AG

$418.64
-10.9%(1M)
Market Cap356.9B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio45.65
ROE41.2%
P/B Ratio9.11
Dividend Yield3.0%
JNJ
JNJ

Johnson & Johnson

$243.19
-0.1%(1M)
Market Cap586.1B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio22.08
ROE33.8%
P/B Ratio7.26
Dividend Yield2.1%
Performance Comparison

Historical returns across multiple timeframes

JNJ leads 8/8
0QQ6.L

0QQ6.L

Roche Holding AG

+1.3%

1Y Return

JNJ

JNJ

Johnson & Johnson

+49.3%

1Y Return

0QQ6.L
0QQ6.L
JNJ
JNJ

Short Term

1M-6M

JNJ
+18.0%

Medium Term

YTD-1Y

JNJ
+33.3%

Long Term

3Y-10Y

JNJ
+78.3%

Valuation

Compare price multiples and valuation ratios

0QQ6.L: 3JNJ: 2
Metric0QQ6.LJNJWinner
P/E Ratio

Price to earnings ratio

45.6522.08JNJ
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.576.240QQ6.L
P/B Ratio

Price to book ratio

9.117.26JNJ
P/FCF Ratio

Price to free cash flow ratio

20.5929.820QQ6.L
EV/EBITDA

Enterprise value to EBITDA

12.7415.360QQ6.L
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

0QQ6.L: 4JNJ: 2
Metric0QQ6.LJNJWinner
Gross Margin

Gross profit margin

73.5%72.8%0QQ6.L
Operating Margin

Operating profit margin

28.4%27.2%0QQ6.L
Net Margin

Net profit margin

12.3%28.5%JNJ
ROE

Return on equity

41.2%33.8%0QQ6.L
ROA

Return on assets

12.8%13.5%JNJ
ROIC

Return on invested capital

18.8%13.7%0QQ6.L

Growth

Compare revenue and earnings growth rates

0QQ6.L: 0JNJ: 6
Metric0QQ6.LJNJWinner
Revenue Growth (YoY)

Year-over-year revenue growth

-1.4%6.0%JNJ
Revenue Growth (3Y)

3-year revenue CAGR

-0.9%5.6%JNJ
Revenue Growth (5Y)

5-year revenue CAGR

1.1%2.7%JNJ
EPS Growth (YoY)

Year-over-year EPS growth

55.9%90.5%JNJ
EPS Growth (3Y)

3-year EPS CAGR

1.1%17.9%JNJ
EPS Growth (5Y)

5-year EPS CAGR

-0.6%14.9%JNJ

Balance Sheet & Risk

Compare financial stability and debt levels

0QQ6.L: 3JNJ: 2
Metric0QQ6.LJNJWinner
Debt/Equity

Debt to equity ratio

1.210.59JNJ
Current Ratio

Current assets to current liabilities

1.291.030QQ6.L
Quick Ratio

Quick assets to current liabilities

1.020.770QQ6.L
Interest Coverage

EBIT to interest expense

10.7326.36JNJ
Beta

Stock volatility vs market

0.210.330QQ6.L
Summary
0QQ6.L wins 3-1

Valuation

0QQ6.L

Profitability

0QQ6.L

Growth

JNJ

Balance Sheet

0QQ6.L

0QQ6.L is more attractively valued. 0QQ6.L shows stronger profitability. JNJ demonstrates better growth. 0QQ6.L has a stronger balance sheet.

Related Comparisons
0QQ6.L 0QQ6.L vs ABBV ABBV0QQ6.L 0QQ6.L vs NVS NVSABBV ABBV vs JNJ JNJJNJ JNJ vs NVS NVS
Take Your Analysis Further

Dive deeper into 0QQ6.L and JNJ with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

Compare 0QQ6.L vs JNJ on stockvs.app
<a href="https://stockvs.app/0QQ6.L/vs/JNJ" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare 0QQ6.L vs JNJ on stockvs.app
</a>